Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early tirofiban treatment for acute ischemic stroke
ChiCTR2000029502Phase 4Completed
- Sponsor
- Xinqiao Hospital
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tirofiban in ischemic stroke (2 arms), sponsored by Xinqiao Hospital. Primary endpoints: Excellent functional outcome at 90 days, Symptomatic intracranial hemorrhage within 48 hours and 1 more. Started Oct 2020; status: completed.
02
Drugs
tirofiban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2000029502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029502.